Sudarshan Pharma Industries to Acquire 9.5% Stake in US-Based MedTherapy Biotech
Mumbai (Maharashtra) , September 7: BSE-listed Sudarshan Pharma Industries Ltd has announced its first major overseas biotech acquisition. In a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure…
